236 results on '"Kortekaas, Jeroen"'
Search Results
2. Novel Toscana Virus Reverse Genetics System Establishes NSs as an Antagonist of Type I Interferon Responses.
3. Safety and immunogenicity of four-segmented Rift Valley fever virus in the common marmoset
4. Creation of Multimeric Single-Domain Antibodies Using Bacterial Superglues
5. Zoonoses Anticipation and Preparedness Initiative, stakeholders conference, February 4 & 5, 2021
6. Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile
7. A single vaccination with four-segmented Rift Valley fever virus prevents vertical transmission of the wild-type virus in pregnant ewes
8. Reproducing the Rift Valley fever virus mosquito-lamb-mosquito transmission cycle
9. Visualizing the ribonucleoprotein content of single bunyavirus virions reveals more efficient genome packaging in the arthropod host
10. Mutation of adjacent cysteine residues in the NSs protein of Rift Valley fever virus results in loss of virulence in mice
11. Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattle
12. Transcriptomic Profiling Reveals Intense Host-Pathogen Dispute Compromising Homeostasis during Acute Rift Valley Fever Virus Infection
13. Quantifying Rift Valley fever virus transmission efficiency in a lamb-mosquito-lamb model
14. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy
15. Two novel porcine teschovirus strains as the causative agents of encephalomyelitis in the Netherlands
16. Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats
17. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination
18. Incomplete bunyavirus particles can cooperatively support virus infection and spread
19. One Health approach to Rift Valley fever vaccine development
20. Neurotropic virus infections as the cause of immediate and delayed neuropathology
21. Suitability of transiently expressed antibodies for clinical studies: product quality consistency at different production scales
22. Perspectives of Next-Generation Live-Attenuated Rift Valley Fever Vaccines for Animal and Human Use.
23. Bead-based suspension array for simultaneous detection of antibodies against the Rift Valley fever virus nucleocapsid and Gn glycoprotein
24. Incomplete bunyavirus particles contribute to within-host spread and between-host transmission
25. Genomic and phylogenetic characterization of Shuni virus
26. Safety and Immunogenicity of Four-Segmented Rift Valley Fever Virus in the Common Marmoset
27. Heterogeneity of Rift Valley fever virus transmission potential across livestock hosts, quantified through a model-based analysis of host viral load and vector infection
28. Genetic characterization of an atypical Schmallenberg virus isolated from the brain of a malformed lamb
29. Predictive Value of Precision-Cut Lung Slices for the Susceptibility of Three Animal Species for SARS-CoV-2 and Validation in a Refined Hamster Model
30. Development of a Modular Vaccine Platform for Multimeric Antigen Display Using an Orthobunyavirus Model
31. Novel Capsid-Specific Single-Domain Antibodies with Broad Foot-and-Mouth Disease Strain Recognition Reveal Differences in Antigenicity of Virions, Empty Capsids, and Virus-Like Particles
32. Animal board invited review: Risks of zoonotic disease emergence at the interface of wildlife and livestock systems
33. Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
34. Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus
35. Additional file 1 of Two novel porcine teschovirus strains as the causative agents of encephalomyelitis in the Netherlands
36. Early recognition and rapid action in zoonotic emergencies : A framework document for the proposed contribution of Wageningen University & Research to a global response for early recognition and rapid action in zoonotic emergencies
37. Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region
38. Shuni Virus Replicates at the Maternal-Fetal Interface of the Ovine and Human Placenta
39. Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB
40. Antibodies against severe fever with thrombocytopenia syndrome virus in healthy persons, China, 2013
41. Visualizing the RNP content of single bunyavirus virions reveals more efficient genome packaging in the arthropod host
42. Early Pathogenesis of Wesselsbron Disease in Pregnant Ewes
43. Obstacles to vaccination of animals and prospective solutions
44. Multimeric single-domain antibody complexes protect against bunyavirus infections
45. Reverse Genetics System for Shuni Virus, an Emerging Orthobunyavirus with Zoonotic Potential
46. Author response: Multimeric single-domain antibody complexes protect against bunyavirus infections
47. Rift Valley fever virus targets the maternal-foetal interface in ovine and human placentas
48. A novel highly sensitive, rapid and safe Rift Valley fever virus neutralization test
49. NSs Filament Formation Is Important but Not Sufficient for RVFV Virulence In Vivo
50. Rift Valley fever: biology and epidemiology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.